ML
Madan Lal Agarwal
About Madan Lal Agarwal
Data last updated:
Madan Lal Agarwal is a Director at Aries Drugs Private Limited (since 2024) and Director at Gemcross Formulation Private Limited (since 2026). The companies operate in Healthcare and Business Services. The largest current company by reported revenue is Aries Drugs Private Limited at ₹2.58 Cr (FY 2024). Earlier, Madan Lal Agarwal was a Director at Caresbridge Remedies Private Limited (2019–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 May 2024 | 2005 | ₹2.58 Cr (FY 2024) | Active | |
| Director | 13 Jul 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Feb 2019 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Madan Lal Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Agarwal | 00660463 | Aries Drugs Private Limited | Managing Director |
| Hari Om Agarwal | 00660604 | Aries Drugs Private Limited | Director |
| Ronak Agrawal | 10612219 | Aries Drugs Private Limited , Gemcross Formulation Private Limited | Director |
| Chitra Agrawal | 08350694 | Gemcross Formulation Private Limited | Individual Subscriber |
| Mayank Agrawal | Gemcross Formulation Private Limited | Individual Subscriber |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Madan Lal Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Madan Lal Agarwal
Madan Lal Agarwal currently holds 2 directorships: Aries Drugs Private Limited (Director, since 02 May 2024, revenue ₹2.58 Cr (FY 2024)); Gemcross Formulation Private Limited (Director, since 13 Jul 2026).
Madan Lal Agarwal was first appointed on 04 Feb 2019 as Director at Caresbridge Remedies Private Limited. The most recent appointment on record is 13 Jul 2026 at Gemcross Formulation Private Limited.
Madan Lal Agarwal held 1 earlier board appointment: Caresbridge Remedies Private Limited (Director, 04 Feb 2019 to 01 Nov 2022).
The current boards of Madan Lal Agarwal's companies include Amit Agarwal (Aries Drugs Private Limited), Hari Om Agarwal (Aries Drugs Private Limited), Ronak Agrawal (Aries Drugs Private Limited), Chitra Agrawal (Gemcross Formulation Private Limited), Mayank Agrawal (Gemcross Formulation Private Limited).